Key statistics
On Thursday, Sana Biotechnology Inc (SANA:NSQ) closed at 2.35, 2.62% above its 52-week low of 2.29, set on Nov 19, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.52 |
---|---|
High | 2.60 |
Low | 2.33 |
Bid | 2.11 |
Offer | 2.75 |
Previous close | 2.53 |
Average volume | 1.91m |
---|---|
Shares outstanding | 223.27m |
Free float | 203.99m |
P/E (TTM) | -- |
Market cap | 524.68m USD |
EPS (TTM) | -1.41 USD |
Data delayed at least 15 minutes, as of Nov 21 2024 21:00 GMT.
More ▼
- Sana Biotechnology Reports Third Quarter 2024 Financial Results and Business Updates
- Sana Biotechnology Announces Increased Focus on Type 1 Diabetes and B-cell Mediated Autoimmune Diseases with the Potential to Deliver Clinical Proof of Concept Data Across Multiple Studies in 2024 and 2025
- Sana Biotechnology to Present at the Goldman Sachs Cell Therapy Day Conference
- Sana Biotechnology to Present at September 2024 Investor Conferences
- Sana Biotechnology Appoints Accomplished Drug Developer Dhaval Patel, M.D., Ph.D., as Executive Vice President and Chief Scientific Officer
- Sana Biotechnology Reports Second Quarter 2024 Financial Results and Business Updates
- Sana Biotechnology Highlights Publication in Nature Biotechnology of Novel In Vivo Preclinical Data Showing the Potential for Pluripotent Stem Cell-Derived Human Glial Progenitor Cell Transplantation as a Treatment for Huntington’s Disease and Other Glial-based Neurodegenerative Conditions
- Sana Biotechnology Reports First Quarter 2024 Financial Results and Business Updates
- Sana Biotechnology to Present at May and June 2024 Investor Conferences
- Sana Biotechnology Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates
More ▼